Literature DB >> 12615631

Sensitivity of spirometric measurements to detect airway obstruction in infants.

Marcus H Jones1, John Howard, Stephanie Davis, Jeff Kisling, Robert S Tepper.   

Abstract

We evaluated the ability of forced expiratory flow volume curves from raised lung volumes to assess airway function among infants with differing severities of respiratory symptoms. Group 1 (n = 33) had previous respiratory symptoms but were currently asymptomatic; group 2 (n = 36) was symptomatic at the time of evaluation. As a control group, we used our previously published sample of 155 healthy infants. Flow volume curves were quantified by FVC, FEF50, FEF75, FEF25-75, FEV0.5, and FEV0.5/FVC, which were expressed as Z scores. All variables except FVC had Z scores that were significantly less than zero and distinguished groups 1 and 2 with progressively lower Z scores. The mean Z scores of the flow variables (FEF50%, FEF75%, and FEF25-75%) were more negative than the Z scores for the timed expired volumes (FEV0.5 or FEV0.5/FVC) for both groups. In general, measures of flow identified a greater number of infants with abnormal lung function than measures of timed volume; FEF50 had the highest performance in detecting abnormal lung function. In summary, forced expiratory maneuvers obtained by the raised volume rapid compression technique can discriminate among groups of infants with differing severity of respiratory symptoms, and measures of forced expiratory flows were better than timed expiratory volume in detecting abnormal airway function.

Entities:  

Mesh:

Year:  2003        PMID: 12615631     DOI: 10.1164/rccm.200204-339OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Oral Vitamin C (500 mg/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized Trial.

Authors:  Cindy T McEvoy; Lyndsey E Shorey-Kendrick; Kristin Milner; Diane Schilling; Christina Tiller; Brittany Vuylsteke; Ashley Scherman; Keith Jackson; David M Haas; Julia Harris; Robert Schuff; Byung S Park; Annette Vu; Dale F Kraemer; Julie Mitchell; Jill Metz; David Gonzales; Carol Bunten; Eliot R Spindel; Robert S Tepper; Cynthia D Morris
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

2.  Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests.

Authors:  Sooky Lum; Per Gustafsson; Henrik Ljungberg; Georg Hülskamp; Andrew Bush; Siobhán B Carr; Rosemary Castle; Ah-Fong Hoo; John Price; Sarath Ranganathan; John Stroobant; Angie Wade; Colin Wallis; Hilary Wyatt; Janet Stocks
Journal:  Thorax       Date:  2006-11-22       Impact factor: 9.139

3.  Nasal versus oronasal raised volume forced expirations in infants--a real physiologic challenge.

Authors:  Mohy G Morris
Journal:  Pediatr Pulmonol       Date:  2012-02-10

4.  Atopy, cytokine production, and airway reactivity as predictors of pre-school asthma and airway responsiveness.

Authors:  Edgar E Sarria; Rita Mattiello; Weiguo Yao; Valentina Chakr; Christina J Tiller; Jeffrey Kisling; Rebeka Tabbey; Zhangsheng Yu; Mark H Kaplan; Robert S Tepper
Journal:  Pediatr Pulmonol       Date:  2013-02-08

5.  Reference values of Forced Expiratory Volumes and pulmonary flows in 3-6 year children: a cross-sectional study.

Authors:  Pavilio Piccioni; Alberto Borraccino; Maria Pia Forneris; Enrica Migliore; Carlo Carena; Elisabetta Bignamini; Stefania Fassio; Giorgio Cordola; Walter Arossa; Massimiliano Bugiani
Journal:  Respir Res       Date:  2007-02-22

6.  Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma.

Authors:  Mario Malerba; Beatrice Ragnoli; Danila Azzolina; Paolo Montuschi; Alessandro Radaeli
Journal:  Front Pharmacol       Date:  2021-04-19       Impact factor: 5.810

7.  Common cold decreases lung function in infants with recurrent wheezing.

Authors:  J Mallol; V Aguirre; G Wandalsen
Journal:  Allergol Immunopathol (Madr)       Date:  2009-11-27       Impact factor: 1.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.